Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 8, Issue 10, Pages e3138
Publisher
Springer Nature
Online
2017-10-26
DOI
10.1038/cddis.2017.512
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation
- (2016) Ning Wu et al. CANCER BIOLOGY & THERAPY
- The protein phosphatase 4 - PEA15 axis regulates the survival of breast cancer cells
- (2016) Hiba N. Mohammed et al. CELLULAR SIGNALLING
- HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models
- (2016) Mariacarla Andreozzi et al. NEOPLASIA
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Expression and Significance of CDC25B, PED/PEA-15 in Esophageal Carcinoma
- (2015) Ming Wang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
- (2015) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- PEA-15 facilitates EGFR dephosphorylationviaERK sequestration at increased ER-PM contacts in TNBC cells
- (2015) Miyoung Shin et al. FEBS LETTERS
- Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma
- (2015) Hou Shan Yao et al. MOLECULAR CARCINOGENESIS
- Advances in targeted therapies for hepatocellular carcinoma in the genomic era
- (2015) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Phosphorylation-Regulated Degradation of the Tumor-Suppressor Form of PED by Chaperone-Mediated Autophagy in Lung Cancer Cells
- (2014) Cristina Quintavalle et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Phosphoprotein enriched in astrocytes (PEA)-15: A potential therapeutic target in multiple disease states
- (2014) Fiona H. Greig et al. PHARMACOLOGY & THERAPEUTICS
- The PEA-15/PED protein regulates cellular survival and invasiveness in colorectal carcinomas
- (2013) Verena Funke et al. CANCER LETTERS
- Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial
- (2013) G. R. Blumenschein et al. CLINICAL CANCER RESEARCH
- Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents
- (2013) Chad Walesky et al. HEPATOLOGY
- Expression of angiogenesis-related gene profiles and development of resistance to tyrosine-kinase inhibitor in advanced renal cell carcinoma: Characterization of sorafenib-resistant cells derived from a cutaneous metastasis
- (2013) Takashi Karashima et al. INTERNATIONAL JOURNAL OF UROLOGY
- A double-negative feedback loop between Wnt–β-catenin signaling and HNF4α regulates epithelial–mesenchymal transition in hepatocellular carcinoma
- (2013) Meng Yang et al. JOURNAL OF CELL SCIENCE
- Epidemiology of Hepatocellular Carcinoma
- (2013) Sahil Mittal et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Suppression of Hepatocyte Proliferation by Hepatocyte Nuclear Factor 4α in Adult Mice
- (2012) Jessica A. Bonzo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PEA-15 unphosphorylated at both serine 104 and serine 116 inhibits ovarian cancer cell tumorigenicity and progression through blocking β-catenin
- (2012) J Lee et al. Oncogenesis
- Hepatocellular carcinoma with extrahepatic metastasis
- (2011) Koji Uchino et al. CANCER
- The stable repression of mesenchymal program is required for hepatocyte identity: A novel role for hepatocyte nuclear factor 4α
- (2011) Laura Santangelo et al. HEPATOLOGY
- PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma
- (2011) Joanna E. Gawecka et al. INTERNATIONAL JOURNAL OF CANCER
- BioProfiling.de: analytical web portal for high-throughput cell biology
- (2011) A. V. Antonov NUCLEIC ACIDS RESEARCH
- miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ
- (2011) C Quintavalle et al. ONCOGENE
- A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
- (2010) S. Roessler et al. CANCER RESEARCH
- Hepatocyte Nuclear Factor 4 Suppresses the Development of Hepatocellular Carcinoma
- (2010) B.-F. Ning et al. CANCER RESEARCH
- Hepatocyte nuclear factor (HNF)-4α-driven epigenetic silencing of the human PED gene
- (2010) P. Ungaro et al. DIABETOLOGIA
- PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells
- (2010) Ciro Zanca et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors
- (2010) Steven JM Jones et al. GENOME BIOLOGY
- Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism
- (2009) Francesca Fiory et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- PEA-15 Induces Autophagy in Human Ovarian Cancer Cells and Is Associated with Prolonged Overall Survival
- (2008) C. Bartholomeusz et al. CANCER RESEARCH
- Molecular Cloning and Characterization of the HumanPED/PEA-15Gene Promoter Reveal Antagonistic Regulation by Hepatocyte Nuclear Factor 4α and Chicken Ovalbumin Upstream Promoter Transcription Factor II
- (2008) Paola Ungaro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer
- (2008) Ciro Zanca et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started